While UV-B phototherapy is a common treatment for patients with atopic dermatitis
(AD), its long-term safety in terms of skin cancer risk has not been explored. Therefore, a study aimed to assess the long-term safety of UV-B phototherapy as a treatment for AD in relation to the risk of developing skin cancer.
Read more at the Journal of the American Academy of Dermatology.